Elawan Energy S.L. (“Elawan”), part of the ORIX group, a global leader in the renewable energy sector, today announced the signing of a 10-year virtual Power Purchase Agreement (PPA) with Sandoz, the global leader in generic and biosimilar medicines. The agreement covers the development of new-build solar projects in Valladolid, Castilla y León, Spain, with a total installed capacity of 150 MW.
This long-term partnership will enable Sandoz to cover nearly 90% of the current electricity consumption of its European operations, representing a major step forward in its decarbonization strategy and its broader commitment to climate action and sustainable practices.
Under the agreement, Sandoz and Elawan Energy will jointly develop new solar projects with a total installed capacity of 150 MW.
Diego Garcia, Head of Revenue Management and PPAs at Elawan, said: “We are proud to partner with Sandoz, the global leader in generic and biosimilar medicines, in this corporate PPA. Supporting Sandoz on their path toward sustainability aligns with our core mission. This agreement represents a significant milestone for Elawan, enabling key projects in our development pipeline to reach commercial operation and reinforcing our commitment to strengthening our role as a leading independent power producer (IPP) in Spain”.
This new partnership with Sandoz adds to Elawan Energy’s growing portfolio of long-term agreements with global corporations committed to clean energy, consolidating the company’s position in delivering scalable, high-impact solutions that drive decarbonization across industries.
